0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Therapy Biomanufacturing Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-18T18519
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Therapy Biomanufacturing Market Research Report 2024
BUY CHAPTERS

Global Cell Therapy Biomanufacturing Market Research Report 2026

Code: QYRE-Auto-18T18519
Report
2026-02-03
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell Therapy Biomanufacturing Market Size

The global Cell Therapy Biomanufacturing market was valued at US$ 10690 million in 2025 and is anticipated to reach US$ 22660 million by 2032, at a CAGR of 11.5% from 2026 to 2032.

Cell Therapy Biomanufacturing Market

Cell Therapy Biomanufacturing Market

Cell therapy biomanufacturing is a comprehensive field that involves the use of biotechnology and engineering principles to produce cell therapy products. Cell therapy biomanufacturing refers to the process of producing, processing and optimizing cells as drugs or treatments through a series of complex bioprocesses. These processes include cell isolation, culture, expansion, modification, and final formulation and quality control, aiming to produce safe, effective and therapeutic cell products.
The North American market for Cell Therapy Biomanufacturing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cell Therapy Biomanufacturing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cell Therapy Biomanufacturing in Skeletal Muscle Repair is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cell Therapy Biomanufacturing include Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, Lonza, Merck KGaA, Thermo Fisher Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cell Therapy Biomanufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Therapy Biomanufacturing. The Cell Therapy Biomanufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell Therapy Biomanufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell Therapy Biomanufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cell Therapy Biomanufacturing Market Report

Report Metric Details
Report Name Cell Therapy Biomanufacturing Market
Accounted market size in 2025 US$ 10690 million
Forecasted market size in 2032 US$ 22660 million
CAGR 11.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Stem Cell
  • Non-Stem Cell
Segment by Application
  • Skeletal Muscle Repair
  • Bone Repair
  • Cancer
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, Lonza, Merck KGaA, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Cell Therapy Biomanufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Cell Therapy Biomanufacturing Market growing?

Ans: The Cell Therapy Biomanufacturing Market witnessing a CAGR of 11.5% during the forecast period 2026-2032.

What is the Cell Therapy Biomanufacturing Market size in 2032?

Ans: The Cell Therapy Biomanufacturing Market size in 2032 will be US$ 22660 million.

Who are the main players in the Cell Therapy Biomanufacturing Market report?

Ans: The main players in the Cell Therapy Biomanufacturing Market are Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, Lonza, Merck KGaA, Thermo Fisher Scientific

What are the Application segmentation covered in the Cell Therapy Biomanufacturing Market report?

Ans: The Applications covered in the Cell Therapy Biomanufacturing Market report are Skeletal Muscle Repair, Bone Repair, Cancer, Cardiovascular Diseases, Neurological Disorders, Others

What are the Type segmentation covered in the Cell Therapy Biomanufacturing Market report?

Ans: The Types covered in the Cell Therapy Biomanufacturing Market report are Stem Cell, Non-Stem Cell

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Biomanufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy Biomanufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Skeletal Muscle Repair
1.3.3 Bone Repair
1.3.4 Cancer
1.3.5 Cardiovascular Diseases
1.3.6 Neurological Disorders
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Biomanufacturing Market Perspective (2021–2032)
2.2 Global Cell Therapy Biomanufacturing Growth Trends by Region
2.2.1 Global Cell Therapy Biomanufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell Therapy Biomanufacturing Historic Market Size by Region (2021–2026)
2.2.3 Cell Therapy Biomanufacturing Forecasted Market Size by Region (2027–2032)
2.3 Cell Therapy Biomanufacturing Market Dynamics
2.3.1 Cell Therapy Biomanufacturing Industry Trends
2.3.2 Cell Therapy Biomanufacturing Market Drivers
2.3.3 Cell Therapy Biomanufacturing Market Challenges
2.3.4 Cell Therapy Biomanufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy Biomanufacturing Players by Revenue
3.1.1 Global Top Cell Therapy Biomanufacturing Players by Revenue (2021–2026)
3.1.2 Global Cell Therapy Biomanufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell Therapy Biomanufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell Therapy Biomanufacturing Revenue
3.4 Global Cell Therapy Biomanufacturing Market Concentration Ratio
3.4.1 Global Cell Therapy Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Biomanufacturing Revenue in 2025
3.5 Global Key Players of Cell Therapy Biomanufacturing Head Offices and Areas Served
3.6 Global Key Players of Cell Therapy Biomanufacturing, Products and Applications
3.7 Global Key Players of Cell Therapy Biomanufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell Therapy Biomanufacturing Breakdown Data by Type
4.1 Global Cell Therapy Biomanufacturing Historic Market Size by Type (2021–2026)
4.2 Global Cell Therapy Biomanufacturing Forecasted Market Size by Type (2027–2032)
5 Cell Therapy Biomanufacturing Breakdown Data by Application
5.1 Global Cell Therapy Biomanufacturing Historic Market Size by Application (2021–2026)
5.2 Global Cell Therapy Biomanufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell Therapy Biomanufacturing Market Size (2021–2032)
6.2 North America Cell Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell Therapy Biomanufacturing Market Size by Country (2021–2026)
6.4 North America Cell Therapy Biomanufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy Biomanufacturing Market Size (2021–2032)
7.2 Europe Cell Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell Therapy Biomanufacturing Market Size by Country (2021–2026)
7.4 Europe Cell Therapy Biomanufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Biomanufacturing Market Size (2021–2032)
8.2 Asia-Pacific Cell Therapy Biomanufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell Therapy Biomanufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell Therapy Biomanufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell Therapy Biomanufacturing Market Size (2021–2032)
9.2 Latin America Cell Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell Therapy Biomanufacturing Market Size by Country (2021–2026)
9.4 Latin America Cell Therapy Biomanufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Biomanufacturing Market Size (2021–2032)
10.2 Middle East & Africa Cell Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell Therapy Biomanufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell Therapy Biomanufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biosenic
11.1.1 Biosenic Company Details
11.1.2 Biosenic Business Overview
11.1.3 Biosenic Cell Therapy Biomanufacturing Introduction
11.1.4 Biosenic Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.1.5 Biosenic Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Cell Therapy Biomanufacturing Introduction
11.2.4 Bristol-Myers Squibb Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Danaher Life Sciences
11.3.1 Danaher Life Sciences Company Details
11.3.2 Danaher Life Sciences Business Overview
11.3.3 Danaher Life Sciences Cell Therapy Biomanufacturing Introduction
11.3.4 Danaher Life Sciences Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.3.5 Danaher Life Sciences Recent Development
11.4 Iovance Biotherapeutics
11.4.1 Iovance Biotherapeutics Company Details
11.4.2 Iovance Biotherapeutics Business Overview
11.4.3 Iovance Biotherapeutics Cell Therapy Biomanufacturing Introduction
11.4.4 Iovance Biotherapeutics Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.4.5 Iovance Biotherapeutics Recent Development
11.5 Lisata Therapeutics
11.5.1 Lisata Therapeutics Company Details
11.5.2 Lisata Therapeutics Business Overview
11.5.3 Lisata Therapeutics Cell Therapy Biomanufacturing Introduction
11.5.4 Lisata Therapeutics Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.5.5 Lisata Therapeutics Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Cell Therapy Biomanufacturing Introduction
11.6.4 Lonza Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.6.5 Lonza Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Cell Therapy Biomanufacturing Introduction
11.7.4 Merck KGaA Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.7.5 Merck KGaA Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Cell Therapy Biomanufacturing Introduction
11.8.4 Thermo Fisher Scientific Revenue in Cell Therapy Biomanufacturing Business (2021–2026)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell Therapy Biomanufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Stem Cell
 Table 3. Key Players of Non-Stem Cell
 Table 4. Global Cell Therapy Biomanufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Cell Therapy Biomanufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Cell Therapy Biomanufacturing Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Cell Therapy Biomanufacturing Market Share by Region (2021–2026)
 Table 8. Global Cell Therapy Biomanufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Cell Therapy Biomanufacturing Market Share by Region (2027–2032)
 Table 10. Cell Therapy Biomanufacturing Market Trends
 Table 11. Cell Therapy Biomanufacturing Market Drivers
 Table 12. Cell Therapy Biomanufacturing Market Challenges
 Table 13. Cell Therapy Biomanufacturing Market Restraints
 Table 14. Global Cell Therapy Biomanufacturing Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Cell Therapy Biomanufacturing Market Share by Players (2021–2026)
 Table 16. Global Top Cell Therapy Biomanufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell Therapy Biomanufacturing Revenue, 2025
 Table 17. Ranking of Global Top Cell Therapy Biomanufacturing Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Cell Therapy Biomanufacturing Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Cell Therapy Biomanufacturing, Headquarters and Area Served
 Table 20. Global Key Players of Cell Therapy Biomanufacturing, Products and Applications
 Table 21. Global Key Players of Cell Therapy Biomanufacturing, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Cell Therapy Biomanufacturing Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Cell Therapy Biomanufacturing Revenue Market Share by Type (2021–2026)
 Table 25. Global Cell Therapy Biomanufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Cell Therapy Biomanufacturing Revenue Market Share by Type (2027–2032)
 Table 27. Global Cell Therapy Biomanufacturing Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Cell Therapy Biomanufacturing Revenue Market Share by Application (2021–2026)
 Table 29. Global Cell Therapy Biomanufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Cell Therapy Biomanufacturing Revenue Market Share by Application (2027–2032)
 Table 31. North America Cell Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Cell Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Cell Therapy Biomanufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Cell Therapy Biomanufacturing Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Cell Therapy Biomanufacturing Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Cell Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Cell Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Cell Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 46. Biosenic Company Details
 Table 47. Biosenic Business Overview
 Table 48. Biosenic Cell Therapy Biomanufacturing Product
 Table 49. Biosenic Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 50. Biosenic Recent Development
 Table 51. Bristol-Myers Squibb Company Details
 Table 52. Bristol-Myers Squibb Business Overview
 Table 53. Bristol-Myers Squibb Cell Therapy Biomanufacturing Product
 Table 54. Bristol-Myers Squibb Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 55. Bristol-Myers Squibb Recent Development
 Table 56. Danaher Life Sciences Company Details
 Table 57. Danaher Life Sciences Business Overview
 Table 58. Danaher Life Sciences Cell Therapy Biomanufacturing Product
 Table 59. Danaher Life Sciences Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 60. Danaher Life Sciences Recent Development
 Table 61. Iovance Biotherapeutics Company Details
 Table 62. Iovance Biotherapeutics Business Overview
 Table 63. Iovance Biotherapeutics Cell Therapy Biomanufacturing Product
 Table 64. Iovance Biotherapeutics Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 65. Iovance Biotherapeutics Recent Development
 Table 66. Lisata Therapeutics Company Details
 Table 67. Lisata Therapeutics Business Overview
 Table 68. Lisata Therapeutics Cell Therapy Biomanufacturing Product
 Table 69. Lisata Therapeutics Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 70. Lisata Therapeutics Recent Development
 Table 71. Lonza Company Details
 Table 72. Lonza Business Overview
 Table 73. Lonza Cell Therapy Biomanufacturing Product
 Table 74. Lonza Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 75. Lonza Recent Development
 Table 76. Merck KGaA Company Details
 Table 77. Merck KGaA Business Overview
 Table 78. Merck KGaA Cell Therapy Biomanufacturing Product
 Table 79. Merck KGaA Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 80. Merck KGaA Recent Development
 Table 81. Thermo Fisher Scientific Company Details
 Table 82. Thermo Fisher Scientific Business Overview
 Table 83. Thermo Fisher Scientific Cell Therapy Biomanufacturing Product
 Table 84. Thermo Fisher Scientific Revenue in Cell Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 85. Thermo Fisher Scientific Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Cell Therapy Biomanufacturing Picture
 Figure 2. Global Cell Therapy Biomanufacturing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Cell Therapy Biomanufacturing Market Share by Type: 2025 vs 2032
 Figure 4. Stem Cell Features
 Figure 5. Non-Stem Cell Features
 Figure 6. Global Cell Therapy Biomanufacturing Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Cell Therapy Biomanufacturing Market Share by Application: 2025 vs 2032
 Figure 8. Skeletal Muscle Repair Case Studies
 Figure 9. Bone Repair Case Studies
 Figure 10. Cancer Case Studies
 Figure 11. Cardiovascular Diseases Case Studies
 Figure 12. Neurological Disorders Case Studies
 Figure 13. Others Case Studies
 Figure 14. Cell Therapy Biomanufacturing Report Years Considered
 Figure 15. Global Cell Therapy Biomanufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Cell Therapy Biomanufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Cell Therapy Biomanufacturing Market Share by Region: 2025 vs 2032
 Figure 18. Global Cell Therapy Biomanufacturing Market Share by Players in 2025
 Figure 19. Global Cell Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Cell Therapy Biomanufacturing Revenue in 2025
 Figure 21. North America Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Cell Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 23. United States Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Cell Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 27. Germany Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Cell Therapy Biomanufacturing Market Share by Region (2021–2032)
 Figure 35. China Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Cell Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 43. Mexico Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Cell Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 47. Israel Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Cell Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Biosenic Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 52. Danaher Life Sciences Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 53. Iovance Biotherapeutics Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 54. Lisata Therapeutics Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 55. Lonza Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 56. Merck KGaA Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Biomanufacturing Business (2021–2026)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc